Minimal access left ventricular reconstruction.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 27 06 2020
revised: 07 09 2020
accepted: 11 09 2020
pubmed: 3 11 2020
medline: 15 5 2021
entrez: 2 11 2020
Statut: ppublish

Résumé

The Revivent TC™ Transcatheter Ventricular Enhancement System (BioVentrix Inc.) is intended for use in heart failure with cardiac dysfunction a previous myocardial infarction. The resultant increased left ventricular systolic volume and discrete, contiguous, noncontractile (akinetic and/or dyskinetic) scar located in the anteroseptal, apical (may extend laterally) region of the left ventricle (LV) lends itself to Revivent. The procedure, called Less Invasive Ventricular Enhancement, consists of the implantation of a series of microanchors pairs to exclude the scarred myocardium, to reduce and reshape the LV. We present the procedure step-by-step, as team coordination between the cardiac surgeon and the interventional cardiologist is essential to ensure good procedural outcomes. This is a novel and new technique to address heart failure secondary to myocardial infarction.

Identifiants

pubmed: 33135236
doi: 10.1111/jocs.15117
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300-306

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Observational study to collect data on health improvements after mini-invasive operation with Revivent TC device to reshape the heart and reduce its volume: BioVentrix Registry Assessment of Ventricular Enhancement for the Revivent TC system (BRAVE- TC). https://doi.org/10.1186/ISRCTN89757315, 2016; http://www.isrctn.com/ISRCTN89757315. Accessed October 1, 2020.
Rouleau JL, Michler RE, Velazquez EJ, et al. The STICH trial: evidence-based conclusions. Eur J Heart Fail. 2010;12(10):1028-1030.
Calafiore AM1, Iacò AL, Amata D, et al. Left ventricular surgical restoration for anteroseptal scars; volume versus shape. J Thorac Cardiovasc Surg. 2010;139(5):1123-1130.
Athanasuleas CL, Buckberg GD, Stanley AWH, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2004;44(7):1439-1445.

Auteurs

Thasee Pillay (T)

BioVentrix Inc., San Ramon, California, USA.

Paulo Neves (P)

BioVentrix Inc., San Ramon, California, USA.
Department of Cardiothoracic Surgery, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.

Federico Benetti (F)

Fundacion Benetti, Santa Fe, Argentina.

Kevin Van Bladel (K)

BioVentrix Inc., San Ramon, California, USA.

Andrew Wechsler (A)

BioVentrix Inc., San Ramon, California, USA.
Department of Cardiothoracic Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Lon Annest (L)

BioVentrix Inc., San Ramon, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH